These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 20206870)

  • 21. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical features of hepatitis C-infected patients with persistently normal alanine transaminase levels in the Southwestern United States.
    Jamal MM; Soni A; Quinn PG; Wheeler DE; Arora S; Johnston DE
    Hepatology; 1999 Nov; 30(5):1307-11. PubMed ID: 10534355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection.
    Martin-Carbonero L; de Ledinghen V; Moreno A; Maida I; Foucher J; Barreiro P; Romero M; Satta G; Garcia-Samaniego J; Gonzalez-Lahoz J; Soriano V
    J Viral Hepat; 2009 Nov; 16(11):790-5. PubMed ID: 19413693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic hepatitis C infection in patients with end stage renal disease: characterization of liver histology and viral load in patients awaiting renal transplantation.
    Sterling RK; Sanyal AJ; Luketic VA; Stravitz RT; King AL; Post AB; Mills AS; Contos MJ; Shiffman ML
    Am J Gastroenterol; 1999 Dec; 94(12):3576-82. PubMed ID: 10606322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances in the treatment of hepatitis C.
    Lawrence SP
    Adv Intern Med; 2000; 45():65-105. PubMed ID: 10635046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities.
    Silini E; Bono F; Cividini A; Cerino A; Bruno S; Rossi S; Belloni G; Brugnetti B; Civardi E; Salvaneschi L
    Hepatology; 1995 Feb; 21(2):285-90. PubMed ID: 7843695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ribavirin in the treatment of hepatitis C.
    Abonyi ME; Lakatos PL
    Anticancer Res; 2005; 25(2B):1315-20. PubMed ID: 15865084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is alanine aminotransferase a good marker of histologic hepatic damage in renal transplant patients with hepatitis C virus infection?
    Perez RM; Ferreira AS; Medina-Pestana JO; Lanzoni VP; Silva AE; Ferraz ML
    Clin Transplant; 2005 Oct; 19(5):622-5. PubMed ID: 16146553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum hepatitis C virus RNA quantity and histological features of hepatitis C virus carriers with persistently normal ALT levels.
    Naito M; Hayashi N; Hagiwara H; Hiramatsu N; Kasahara A; Fusamoto H; Kamada T
    Hepatology; 1994 Apr; 19(4):871-5. PubMed ID: 8138259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C virus infection acquired in childhood.
    Camarero C; Ramos N; Moreno A; Asensio A; Mateos ML; Roldan B
    Eur J Pediatr; 2008 Feb; 167(2):219-24. PubMed ID: 17464514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HCV and HGV infection, iron overload and liver disease in multitransfused patients with thalassaemia and persistently normal or abnormal transaminase levels.
    Gamberini MR; Francesconi R; Fortini M; Cavazzini L; Lari F; Scapoli C; Ballardini G; De Sanctis V; Bianchi FB
    Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():259-66. PubMed ID: 16462707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity.
    Mathurin P; Moussalli J; Cadranel JF; Thibault V; Charlotte F; Dumouchel P; Cazier A; Huraux JM; Devergie B; Vidaud M; Opolon P; Poynard T
    Hepatology; 1998 Mar; 27(3):868-72. PubMed ID: 9500720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of liver histology, ALT elevation, and HCV RNA titer in patients with chronic hepatitis C.
    McCormick SE; Goodman ZD; Maydonovitch CL; Sjogren MH
    Am J Gastroenterol; 1996 Aug; 91(8):1516-22. PubMed ID: 8759653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.
    Barreiro P; Martín-Carbonero L; Núñez M; Rivas P; Morente A; Simarro N; Labarga P; González-Lahoz J; Soriano V
    Clin Infect Dis; 2006 Apr; 42(7):1032-9. PubMed ID: 16511772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of liver biopsy in hepatitis C.
    Perrillo RP
    Hepatology; 1997 Sep; 26(3 Suppl 1):57S-61S. PubMed ID: 9305665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA.
    Martinot-Peignoux M; Boyer N; Cazals-Hatem D; Pham BN; Gervais A; Le Breton V; Levy S; Degott C; Valla DC; Marcellin P
    Hepatology; 2001 Nov; 34(5):1000-5. PubMed ID: 11679971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of alanine aminotransferase flare-up among asymptomatic hepatitis C virus RNA carriers: a 10-year follow-up study.
    Tsuji K; Yamasaki K; Yamanishi M; Kawakami M; Shirahama S
    J Gastroenterol Hepatol; 2001 May; 16(5):536-40. PubMed ID: 11350550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sustained virological response following extremely short antiviral treatment in selected HCV carriers with persistently normal ALT.
    Puoti C; Guarisco R; Spilabotti L; Bellis L
    Dig Liver Dis; 2010 Oct; 42(10):745. PubMed ID: 20303840
    [No Abstract]   [Full Text] [Related]  

  • 40. Histological and virological features and follow-up of hepatitis C virus carriers with normal aminotransferase levels: the Italian prospective study of the asymptomatic C carriers (ISACC).
    Puoti C; Castellacci R; Montagnese F; Zaltron S; Stornaiuolo G; Bergami N; Bellis L; Precone DF; Corvisieri P; Puoti M; Minola E; Gaeta GB
    J Hepatol; 2002 Jul; 37(1):117-23. PubMed ID: 12076870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.